O Caffo

Summary

Country: Italy

Publications

  1. ncbi request reprint Concurrent adjuvant chemotherapy and immediate breast reconstruction with skin expanders after mastectomy for breast cancer
    O Caffo
    Medical Oncology Department, St Chiara Hospital, Trento, Italy
    Breast Cancer Res Treat 60:267-75. 2000
  2. ncbi request reprint Multiple rechallenges (ReCs) with docetaxel (DOC) as an option after first-line therapy in patients (pts) with castration-resistant prostate cancer (CRPC)
    O Caffo
    Medical Oncology Department, Santa Chiara Hospital, Trento, Italy Santa Chiara Hospital, Trento, Italy
    J Clin Oncol 29:165. 2011
  3. ncbi request reprint Gemcitabine (G) and cisplatin (C) in a modified 3-week schedule for non-small cell lung cancer (NSCLC): Impact on hematologic toxicity and dose intensity (DI)
    O Caffo
    Santa Chiara Hospital, Trento, Italy
    J Clin Oncol 26:19099. 2008
  4. ncbi request reprint Microinvasive breast cancer (Tmic): A descriptive mono-institutional report
    A Ferro
    St Chiara Hospital, Trento, Italy
    J Clin Oncol 26:11508. 2008
  5. ncbi request reprint Cisplatin (C) and gemcitabine (G) chemotherapy with concurrent irradiation (XRT), for the conservative treatment of invasive transitional bladder cancer (ITBC) patients: Clinical outcome and long-term follow-up in a monoinstitutional experience
    O Caffo
    Santa Chiara Hospital, Trento, Italy
    J Clin Oncol 27:e16081. 2009
  6. ncbi request reprint Real-time quality assessment of cancer care through information technology instruments incorporated into routine clinical practice
    E Galligioni
    Santa Chiara Hospital, Trento, Italy Fondazione Bruno Kessler, Trento, Italy
    J Clin Oncol 27:6620. 2009
  7. ncbi request reprint Individual risk factors for venous thromboembolism (VTE) in cancer patients treated with targeted therapies (TT)
    B Soini
    S Chiara Hospital, Trento, Italy Fondazione Bruno Kessler, Trento, Italy S Maria degli Angeli Hospital, Pordenone, Italy
    J Clin Oncol 27:e20549. 2009
  8. ncbi request reprint Predictive factors of response to docetaxel (DOC) rechallenge (ReC) in castration-resistant prostate cancer (CRPC) patients (pts)
    A Veccia
    Santa Chiara Hospital, Trento, Italy S Chiara hospital, Trento, Italy Azienda ULSS 13, Mirano, Italy
    J Clin Oncol 29:e15126. 2011
  9. ncbi request reprint Role of Ki67 labeling index (LI) in subdividing homogeneous ER-positive grading groups of early breast cancer (EBC) in distinct biologic entities
    A Ferro
    Santa Chiara Hospital, Trento, Italy Histopathology, Santa Chiara Hospital, Trento, Italy Center for Scientific and Technological Research, Fondazione Bruno Kessler, Trento, Italy FBK, Trento, Italy S Chiara hospital, Trento, Italy
    J Clin Oncol 29:539. 2011
  10. ncbi request reprint Gemcitabine (G) and epirubicin (E) combination, in platinum-resistant or refractory advanced ovarian cancer (PROC) patients: Results of a multicentric phase II trial
    V Murgia
    Santa Chiara Hospital, Trento, Italy Oncology Center, Aviano, Italy Civil Hospital, Verona, Italy Oncology Center, Aviano, Italy Civil Hospital, Pordenone, Italy
    J Clin Oncol 26:5566. 2008

Collaborators

Detail Information

Publications19

  1. ncbi request reprint Concurrent adjuvant chemotherapy and immediate breast reconstruction with skin expanders after mastectomy for breast cancer
    O Caffo
    Medical Oncology Department, St Chiara Hospital, Trento, Italy
    Breast Cancer Res Treat 60:267-75. 2000
    ..The present study reports our experience in the use of concurrent adjuvant chemotherapy and immediate breast reconstruction with skin expander after mastectomy for breast cancer and the acute cumulative toxicity of the treatments...
  2. ncbi request reprint Multiple rechallenges (ReCs) with docetaxel (DOC) as an option after first-line therapy in patients (pts) with castration-resistant prostate cancer (CRPC)
    O Caffo
    Medical Oncology Department, Santa Chiara Hospital, Trento, Italy Santa Chiara Hospital, Trento, Italy
    J Clin Oncol 29:165. 2011
    ..The available data usually report on the clinical outcome of pts who have received one or two ReCs, but it is unclear whether more ReCs may be offered to these pts and if there is a maximum number of affordable ReCs...
  3. ncbi request reprint Gemcitabine (G) and cisplatin (C) in a modified 3-week schedule for non-small cell lung cancer (NSCLC): Impact on hematologic toxicity and dose intensity (DI)
    O Caffo
    Santa Chiara Hospital, Trento, Italy
    J Clin Oncol 26:19099. 2008
    ..This report presents our experience with a modified 3-week schedule, that we have adopted into the daily clinical practice...
  4. ncbi request reprint Microinvasive breast cancer (Tmic): A descriptive mono-institutional report
    A Ferro
    St Chiara Hospital, Trento, Italy
    J Clin Oncol 26:11508. 2008
    ..We present our retrospective review of 69 cases of Tmic, among 6,023 BC pts (1%), observed at our institution from 1990 to 2007...
  5. ncbi request reprint Cisplatin (C) and gemcitabine (G) chemotherapy with concurrent irradiation (XRT), for the conservative treatment of invasive transitional bladder cancer (ITBC) patients: Clinical outcome and long-term follow-up in a monoinstitutional experience
    O Caffo
    Santa Chiara Hospital, Trento, Italy
    J Clin Oncol 27:e16081. 2009
    ..We are presenting the long-term clinical outcome of the 16 patients involved in the dose-finding trial, together with that of the 9 pts enrolled in the phase II study...
  6. ncbi request reprint Real-time quality assessment of cancer care through information technology instruments incorporated into routine clinical practice
    E Galligioni
    Santa Chiara Hospital, Trento, Italy Fondazione Bruno Kessler, Trento, Italy
    J Clin Oncol 27:6620. 2009
    ....
  7. ncbi request reprint Individual risk factors for venous thromboembolism (VTE) in cancer patients treated with targeted therapies (TT)
    B Soini
    S Chiara Hospital, Trento, Italy Fondazione Bruno Kessler, Trento, Italy S Maria degli Angeli Hospital, Pordenone, Italy
    J Clin Oncol 27:e20549. 2009
    ..In this report, we have evaluated the incidence of VTE and assessed the predictive value of the Khorana's model, in cancer patients receiving TT, alone or combined with CT...
  8. ncbi request reprint Predictive factors of response to docetaxel (DOC) rechallenge (ReC) in castration-resistant prostate cancer (CRPC) patients (pts)
    A Veccia
    Santa Chiara Hospital, Trento, Italy S Chiara hospital, Trento, Italy Azienda ULSS 13, Mirano, Italy
    J Clin Oncol 29:e15126. 2011
    ..The possibility of obtaining a new response by a DOC ReC is usually considered on the basis of the response to the previous treatment. We attempt to identify if there are additional factors able to predict ReC response...
  9. ncbi request reprint Role of Ki67 labeling index (LI) in subdividing homogeneous ER-positive grading groups of early breast cancer (EBC) in distinct biologic entities
    A Ferro
    Santa Chiara Hospital, Trento, Italy Histopathology, Santa Chiara Hospital, Trento, Italy Center for Scientific and Technological Research, Fondazione Bruno Kessler, Trento, Italy FBK, Trento, Italy S Chiara hospital, Trento, Italy
    J Clin Oncol 29:539. 2011
    ..Our study aimed to evaluate if these cutoffs can be used in different subgroups of EBC, or if to apply different cutoffs in distinct biological setting...
  10. ncbi request reprint Gemcitabine (G) and epirubicin (E) combination, in platinum-resistant or refractory advanced ovarian cancer (PROC) patients: Results of a multicentric phase II trial
    V Murgia
    Santa Chiara Hospital, Trento, Italy Oncology Center, Aviano, Italy Civil Hospital, Verona, Italy Oncology Center, Aviano, Italy Civil Hospital, Pordenone, Italy
    J Clin Oncol 26:5566. 2008
    ..The efficacy and toxicity of GE combination in PROC pts, has been evaluated in our group in a phase II study and is presented in this report...
  11. ncbi request reprint Quality of life in patients with early stage breast carcinoma treated with conservation surgery and radiotherapy. An Italian monoinstitutional study
    M Amichetti
    Department of Radiation Oncology, Santa Chiara Hospital, Trento, Italy
    Tumori 87:78-84. 2001
    ..To evaluate the quality of life (QOL) in patients with early stage invasive carcinoma of the breast treated with conservative surgery and postoperative irradiation...
  12. ncbi request reprint p27(kip1) expression in breast carcinomas: an immunohistochemical study on 512 patients with long-term follow-up
    M Barbareschi
    Department of Histopathology, St Chiara Hospital, Trento, Italy
    Int J Cancer 89:236-41. 2000
    ..We also investigated the prognostic value of the combined expression of p27 and cyclin D1, but no differences in survival were seen in this bivariate analysis...
  13. ncbi request reprint Brain and meningeal metastases (BMm) from castration-resistant prostate cancer (CRPC) in the era of docetaxel (DOC)
    O Caffo
    Medical Oncology Department, Santa Chiara Hospital, Trento, Italy Oncology Unit, Policlinico, Bari, Italy Divisione Universitaria di Oncologia ed Ematologia, Istituto per la Ricerca e la Cura del Cancro, Candiolo, Italy Civil Hospital, Verona, Italy Oncology, Cardarelli, Napoli, Italy National Cancer Institute, Naples, Italy Garibaldi Hospital, Catania, Italy Santa Chiara Hospital, Trento, Italy Urology Unit II, Policlinico, Bari, Italy
    J Clin Oncol 29:217. 2011
    ..5%. Since the introduction of DOC as first line treatment has improved survival of CRPC pts, we have retrospectively evaluated the occurrence of BMm in such setting of pts, to explore whether the incidence of BMm has changed...
  14. ncbi request reprint Impact of interstitial brachytherapy (IB) or radical prostatectomy (RP) on quality of life (QL) of patients (pts) treated for localized prostate cancer (LPC): Medium-term outcomes from a prospective monoinstitutional study
    O Caffo
    Santa Chiara Hospital, Trento, Italy
    J Clin Oncol 29:e15108. 2011
    ..e15108 Background: Pts with LPC may be treated by different therapies which have similar disease control rates but potentially relevant differences in terms of QL impact. We attempted to evaluate the changes of QL after IB or RP...
  15. ncbi request reprint Prognostic value of positron emission tomography (PET) in patients (pts) with metastatic or locally advanced cervical cancer (CC): A monoinstitutional experience
    V Murgia
    Santa Chiara Hospital, Trento, Italy Nuclear Medicine Department, Santa Chiara Hospital, Trento, Italy Department of Radiation Oncology, Santa Chiara Hospital, Trento, Italy S Chiara hospital, Trento, Italy Gynecology Department, Santa Chiara Hospital, Trento, Italy
    J Clin Oncol 29:e15591. 2011
    ..The present report is aimed to evaluate the prognostic role of PET in CC patients treated with chemotherapy (CT) alone or concurrent chemo/radiotherapy (CT/RT)...
  16. doi request reprint Development and daily use of an electronic oncological patient record for the total management of cancer patients: 7 years' experience
    E Galligioni
    Department of Medical Oncology, Santa Chiara Hospital, Trento, Italy
    Ann Oncol 20:349-52. 2009
    ..We describe our experience with an electronic oncological patient record (EOPR) for the total management of cancer patients...
  17. ncbi request reprint Quality of life after radiotherapy for early-stage testicular seminoma
    O Caffo
    Department of Medical Oncology, St. Chiara Hospital, 38100, Trento, Italy
    Radiother Oncol 59:13-20. 2001
    ..CONCLUSIONS: The QL in our patients resulted as satisfactory, with a maintained body image and few side-effects. The information given to the patients about their disease and its treatment influenced the post-treatment QL adjustment...
  18. pmc Biological characterisation of superficial bladder cancer by bivariate cytokeratin 7/DNA analysis, flow cytometric assessment of MIB- 1, and an immunohistochemical study
    E Leonardi
    Department of Pathology, St Chiara Hospital, Trento, Italy
    Anal Cell Pathol 21:21-33. 2000
    ..The determination of DNA content coupled with the study of the epithelial (cytokeratin 7) and proliferative (MIB-1) markers could be useful in providing important information on the biological behaviour of superficial bladder tumours...
  19. ncbi request reprint Subclinical ductal carcinoma in situ of the breast: treatment with conservative surgery and radiotherapy
    M Amichetti
    Radiation Oncology Department, Santa Chiara Hospital, Trento, Italy
    Tumori 85:488-93. 1999
    ....